Boltwood Capital Management Abb Vie Inc. Transaction History

Boltwood Capital Management

$336 Million
Q3 2024

A detailed history of Boltwood Capital Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Boltwood Capital Management holds 7,165 shares of ABBV stock, worth $1.27 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

7,165

Previous 7,210 0.62%

Holding current value

$1.27 Million

Previous $1.24 Million 14.4%

% of portfolio

0.42%

Previous 0.39%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 02, 2024	SELL	$163.84 - $199.33 $7,372 - $8,969	-45 Reduced 0.62%	7,165 $1.41 Million
Q2 2024 Jul 08, 2024	BUY	$154.79 - $180.76 $1,547 - $1,807	10 Added 0.14%	7,210 $1.24 Million
Q1 2024 Apr 04, 2024	SELL	$159.82 - $182.1 $43,790 - $49,895	-274 Reduced 3.67%	7,200 $1.31 Million
Q4 2023 Jan 05, 2024	SELL	$137.6 - $154.97 $6,880 - $7,748	-50 Reduced 0.66%	7,474 $1.16 Million
Q3 2023 Oct 10, 2023	SELL	$133.59 - $154.65 $16,030 - $18,558	-120 Reduced 1.57%	7,524 $1.12 Million
Q2 2023 Jul 06, 2023	SELL	$132.51 - $164.9 $15,901 - $19,788	-120 Reduced 1.55%	7,644 $1.03 Million
Q1 2023 Apr 03, 2023	BUY	$144.61 - $166.54 $36,152 - $41,635	250 Added 3.33%	7,764 $1.24 Million
Q4 2022 Jan 06, 2023	SELL	$138.31 - $165.87 $23,789 - $28,529	-172 Reduced 2.24%	7,514 $0
Q3 2022 Oct 04, 2022	SELL	$134.21 - $153.93 $12,213 - $14,007	-91 Reduced 1.17%	7,686 $1.03 Million
Q2 2022 Jul 07, 2022	SELL	$137.62 - $174.96 $7,156 - $9,097	-52 Reduced 0.66%	7,777 $1.19 Million
Q1 2022 Apr 20, 2022	SELL	$131.98 - $163.75 $33,126 - $41,101	-251 Reduced 3.11%	7,829 $1.27 Million
Q4 2021 Jan 10, 2022	SELL	$107.43 - $135.93 $6,230 - $7,883	-58 Reduced 0.71%	8,080 $1.09 Million
Q3 2021 Oct 08, 2021	SELL	$106.4 - $120.78 $15,960 - $18,117	-150 Reduced 1.81%	8,138 $878,000
Q2 2021 Jul 06, 2021	SELL	$105.21 - $117.21 $18,516 - $20,628	-176 Reduced 2.08%	8,288 $934,000
Q1 2021 Apr 05, 2021	SELL	$102.3 - $112.62 $14,526 - $15,992	-142 Reduced 1.65%	8,464 $916,000
Q3 2020 Oct 05, 2020	SELL	$85.91 - $100.83 $3,694 - $4,335	-43 Reduced 0.5%	8,606 $754,000
Q2 2020 Jul 02, 2020	SELL	$73.37 - $98.18 $4,035 - $5,399	-55 Reduced 0.63%	8,649 $849,000
Q1 2020 Apr 07, 2020	SELL	$64.5 - $97.79 $33,540 - $50,850	-520 Reduced 5.64%	8,704 $663,000
Q1 2019 Apr 02, 2019	SELL	$77.14 - $90.79 $711,539 - $837,446	-9,224 Closed	0 $0
Q2 2018 Jul 06, 2018	SELL	$89.78 - $106.23 $17,956 - $21,246	-200 Reduced 2.12%	9,224 $854,000
Q1 2018 Apr 05, 2018	SELL	$92.01 - $123.21 $135,990 - $182,104	-1,478 Reduced 13.56%	9,424 $891,000
Q3 2017 Oct 10, 2017	BUY	$69.85 - $89.22 $761,504 - $972,676	10,902	10,902 $968,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boltwood Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Boltwood Capital Management with notifications on news.

Account

Boltwood Capital Management Abb Vie Inc. Transaction History